{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-127611","form_type":"8-K","ticker":"CRVS","cik":"0001626971","company_name":"Corvus Pharmaceuticals, Inc.","filed_at":"2024-05-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.309608+00:00","generated_at":"2026-06-03T02:53:47.135913+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Corvus cuts ATM program ceiling from $90M to $8.2M; nearly all capacity used","bullets":["Amendment reduces aggregate offering price under Jefferies ATM from $90M to $8.2M.","Approximately $8.1M of shares sold to date, leaving ~$100,000 remaining availability.","Program originally entered into on March 28, 2023; amendment dated May 1, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-127611","json":"https://secwatch.observer/filing/0001193125-24-127611.json","markdown":"https://secwatch.observer/filing/0001193125-24-127611.md","text":"https://secwatch.observer/filing/0001193125-24-127611.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1626971/000119312524127611/0001193125-24-127611-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1626971/000119312524127611/d779751d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T02:53:47.135913+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}